Scarica l'app Stockscreener
1.44
2.70%
-0.04
Pre-mercato:
1.39
-0.05
-3.47%
Precedente Chiudi:
$1.48
Aprire:
$1.32
Volume 24 ore:
2.50M
Relative Volume:
3.06
Capitalizzazione di mercato:
$126.37M
Reddito:
$361.07M
Utile/perdita netta:
$-71.54M
Rapporto P/E:
-1.8228
EPS:
-0.79
Flusso di cassa netto:
$-47.97M
1 W Prestazione:
+29.73%
1M Prestazione:
+98.90%
6M Prestazione:
+358.74%
1 anno Prestazione:
-3.36%
Intervallo 1D:
$1.03
$1.44
Intervallo di 1 settimana:
$0.97
$1.59
Portata 52W:
$0.1253
$1.63
Oncology Institute Inc Stock (TOI) Company Profile
Nome
Oncology Institute Inc
Settore
Industria
Telefono
562-735-3226
Indirizzo
18000 STUDEBAKER RD, CERRITOS
Confronta TOI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
1.44 | 126.37M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
349.14 | 85.96B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.66 | 15.06B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
132.86 | 12.98B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
153.73 | 12.30B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
188.73 | 12.27B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2022-09-14 | Iniziato | Guggenheim | Buy |
| 2022-08-15 | Iniziato | Jefferies | Buy |
Oncology Institute Inc Borsa (TOI) Ultime notizie
A Data-Based Look At Oncology Institute Inc (TOI) - stocksregister.com
Virtu Financial LLC Takes $41,000 Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
TOI Launches Florida Oncology Network, a Fully Delegated - GlobeNewswire
The Oncology Institute announces launch of the Florida Oncology Network - TipRanks
Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts - Stock Titan
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute CEO acquires $23,584 in stock By Investing.com - Investing.com Australia
Oncology institute’s chief medical officer buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
Oncology institute director Karen Johnson acquires $37,734 in shares By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase By Investing.com - Investing.com South Africa
Oncology institute director Brad Hively acquires $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock - Investing.com India
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com
Oncology Institute Executives Make Significant Stock Purchases - TradingView
Oncology institute director Karen Johnson acquires $37,734 in shares - Investing.com
Oncology institute director Richard Barasch acquires $1.42 million in shares By Investing.com - Investing.com South Africa
Oncology institute director Richard Barasch acquires $1.42 million in shares - Investing.com India
Oncology institute CFO Robert Ross buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges - MSN
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript - Insider Monkey
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million - Yahoo Finance
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
The Oncology Institute Reports Strong Q4 Revenue Growth - TipRanks
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth - Investing.com Australia
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth By Investing.com - Investing.com South Africa
The Oncology Institute Announces $16.5 million Private Placement - GlobeNewswire
The Oncology Institute Secures $16.5 Million In Private Placement - Nasdaq
Oncology Institute, Inc. Prepares for PIPE Financing - TipRanks
The Oncology Institute, Inc. Announces $16.5 Million Private Placement Agreement - Nasdaq
Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - StockTitan
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - GlobeNewswire
Oncology Institute Lands Major $16.5M Backing as Insiders Double Down - Stock Titan
Wilmot Cancer Institute earns prestigious National Cancer Institute designation - THE WELLSVILLE SUN
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute Inc Azioni (TOI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):